CopMich is held every two years with locations switching between Ann Arbor, Michigan and Copenhagen, Denmark. It is a continuation of an "old" collaboration between the Department of Urology, University of Michigan and the Department of Urology, Herlev and Gentofte Hospital & University of Copenhagen. 

The two departments have a long history of collaboration in the areas of research, education and clinical care, focusing efforts on the area of Andrology, but more recently, attempting to expand their relationship into other subspecialties of Urology.

The Edward J. McGuire, MD, Research Professorship in Urology was established through a generous gift from Brian and Mary Campbell, as well as other gifts to the Department of Urology, in honor of Dr. McGuire. 

Dr. McGuire was a huge force in American urology and a formative figure in the interface between gynecology and urology. The McGuire Lecture is held every two years and brings a foremost expert in the field of neurourology, urodynamics, and urinary incontinence to Ann Arbor to present to our residents and faculty.

The Ann Arbor Health Services Research Symposium is held every two years. 

The goal of the symposium is to bring together clinicians, researchers, students and fellows to discuss cutting-edge topics in health services research.

The Montie Lecture is held biennially in honor of Dr. James E. Montie.

It brings thought-leaders in the field of urologic oncology to Ann Arbor to present to our residents and faculty.

The Duckett Lecture began in 1997, shortly after Dr. John W. Duckett passed away, to honor his legacy. 

It recognizes the connections he helped build between Ann Arbor and the Children's Hospital of Philadelphia, which played a defining role in the development of pediatric urology.

The Montie-Shumaker Lecture Series in Renal Cell Cancer seeks to bring leading voices in the research and treatment of renal cell cancer to southeastern Michigan. It is named in honor of Dr. James Montie, the founding chairman of the University of Michigan Department of Urology and his friend and former patient, Tom Shumaker.

Aided by cutting-edge treatment from specialists like Dr. Montie, Mr. Shumaker lived and thrived as a renal cell cancer patient for over 20 years. During this time, he defied conventional thought of what life with cancer looks like and was a source of inspiration and hope for all of those around him. This lecture series is made possible by a gift from his wife, Sharon Shumaker.

The annual Nesbit Society Urologic Meeting is conducted over the course of a Thursday afternoon and Friday each fall, preceding a U-M home football game. Created in honor of Dr. Reed M. Nesbit, who was one of the foremost figures in the burgeoning specialty of genitourinary surgery during his years of practice from 1928-1968, the Society is open to all current and former faculty members, residents, and fellows and others interested in supporting the mission of the U-M Department of Urology. 

The professorship seeks to promote urological teaching; the art of urological surgery and urological research; and the dissemination of information concerning urology to the membership and the general public, for the benefit of society as a whole.

The Weisbach Lecture is delivered annually by an international leader in prostate cancer research and is dedicated to the memory of Jerry Weisbach who died of prostate cancer on May 24, 2002. 

Jerry was a longtime resident of Ann Arbor and an active supporter of the University of Michigan. Jerry had a distinguished career in the pharmaceutical industry, first at Smith Kline Glaxo, and then at Warner Lambert Parke Davis. His main focus was on drug research and development, and included numerous medical disciplines and cancer. Under his direction, Lipitor was discovered at Warner Lambert. Subsequent to that, he became one of the leading practitioners of technology transfer and served as a consultant, board member and scientific advisor to many biotechnology companies. After developing prostate cancer in 1991, he became particularly interested in - and encouraged research on - a variety of treatments, thereby facilitating production of new, safer and more effective therapies.